Articles Tagged With: transparency
-
Price Transparency or Price Gouging: Disclosure of Negotiated Rates Called a ‘Tipping Point’
How much does a health insurance company pay the hospital for an MRI? Nobody really knows — except the hospital and payer. That is about to change, thanks to a new rule that requires hospitals to disclose secret negotiated rates with payers.
-
Hospitals to Disclose Rates Negotiated With Health Insurance Companies
As of January 2021, they will need to disclose negotiated rates with individual insurers, information that always has been closely guarded, under a final rule issued by CMS.
-
Surgery Centers Could Play Lead Role in Healthcare Transparency
Healthcare transparency is gaining public support, but still faces multiple obstacles to becoming a broad reality across the industry. Some surgery centers are leading the way in making costs and outcomes transparent through their websites.
-
Many Continue Asking Age-Old Question: ‘Why Do Hospitals Charge So Much?’
A growing number of states are enacting laws to control the cost of healthcare, including services rendered at hospitals.
-
Full August 1, 2007 Issue in PDF
-
Hormonal contraception and HIV risk: A review
Results from past research studies have investigated a possible relationship between hormonal contraceptive use and HIV acquisition, but understanding remained poor due to inconsistent results and shortfalls in study design. -
Managing ARDS: Steroid Saga Sequel
This multicenter, randomized, double-blind, placebo-controlled trial finds that early initiation of low-dose, prolonged glucocorticosteroid therapy for ARDS results in improved lung injury scores and a greater likelihood of successful extubation by day 7. -
An Analysis of HPV Vaccine Efficacy in Preventing Cervical Cancer
In an analysis of four clinical trials designed to assess the efficacy of two different human papilloma virus (HPV) vaccines, the appearance of pre-neoplastic lesions and neoplastic cervical adenocarcinoma was dramatically reduced in vaccinated subjects. -
Hepatic Intra-Arterial Paclitaxel for Breast Cancer Metastases
In a pilot study, ten women with liver predominant metastatic breast cancer were treated with intra-hepatic arterial infusion of paclitaxel (200 mg/m2 over 24 hours, monthly). -
Healthcare Infection Prevention: Isolation presents many obstacles in long-term care
Preventing transmission of multidrug-resistant organisms (MDROs) presents particular challenges in the long-term care setting, where residents are encouraged to interact and single rooms are typically at a premium.